Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control. (Q52898823)

9 May 2018

title

Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control. (English)

1 reference

9 May 2018

1 reference

10

1 reference

9 May 2018

Carmen Scheibenbogen

2

object named as

Carmen Scheibenbogen

1 reference

9 May 2018

Wolfgang Poller

12

object named as

Wolfgang Poller

1 reference

9 May 2018

author name string

Peter Bobbert

1

1 reference

9 May 2018

Alexander Jenke

3

1 reference

9 May 2018

Gabriele Kania

4

1 reference

9 May 2018

Sabrina Wilk

5

1 reference

9 May 2018

Stefanie Krohn

6

1 reference

9 May 2018

Jenny Stehr

7

1 reference

9 May 2018

Uwe Kuehl

8

1 reference

9 May 2018

Ursula Rauch

9

1 reference

9 May 2018

Heinz Peter Schultheiss

11

1 reference

9 May 2018

Carsten Skurk

13

1 reference

9 May 2018

publication date

29 January 2011

1 reference

9 May 2018

published in

European Heart Journal

1 reference

9 May 2018

volume

32

1 reference

9 May 2018

issue

9

1 reference

9 May 2018

page(s)

1134-1147

1 reference

9 May 2018

Adiponectin is synthesized and secreted by human and murine cardiomyocytes.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Changes of adiponectin oligomer composition by moderate weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Adiponectin-mediated modulation of hypertrophic signals in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Circulating adiponectin concentrations in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Adiponectin is a negative regulator of NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Adiponectin and inflammation: consensus and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Impaired expression of cardiac adiponectin in leptin-deficient mice with viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: Immunoglobulin G3 and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Infection, mimics, and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Candesartan improves myocardial damage in obese mice with viral myocarditis and induces cardiac adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ498

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHQ498

1 reference

9 May 2018

PubMed ID

21278397

1 reference

9 May 2018